Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Tag: mortality


Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials

May 10th 2022

Based on the results of more than 200 randomized trials, HbA1c is not a valid surrogate marker for all-cause mortality in people with type 2 diabetes (Acta Diabetologica)

Categories: Monitoring, News
Tags: HbA1c, mortality, Type 2 Diabetes

Categories: Monitoring
Tags: HbA1c, mortality, Type 2 Diabetes

Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes

May 10th 2022

CVD and LLA conferred a similar burden regarding mortality in type 1 diabetes population. Our findings encourage a careful consideration of people with type 1 diabetes and LLA as usually recommended for those with CVD, in terms of management of risk factors, treatments and prevention (Cardiovascular Diabetology)

Categories: Cardiovascular, Monitoring, News
Tags: amputation, mortality, Type 1 Diabetes

Categories: Cardiovascular, Monitoring
Tags: amputation, mortality, Type 1 Diabetes

Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts

March 23rd 2022

This is the first multicountry analysis of six large contemporary population-based studies, and shows that all-cause mortality in people with type 1 diabetes has declined in recent years in most studied populations. However, excess mortality relative to the population without diabetes remains high in people with type 1 diabetes (Diabetologia)

Categories: News, Prevalence
Tags: international, mortality, Type 1 Diabetes

Categories: Prevalence
Tags: international, mortality, Type 1 Diabetes

Mortality Rate Associated with Diabetes: Outcomes From a General Practice Level Analysis in England Using the Royal College of General Practitioners (RCGP) Database Indicate Stability Over a 15 Year Period

February 22nd 2022

There remains a wide variation in mortality rate of people with diabetes between general practices in UK. The mortality rate and life years lost for people with diabetes vs non-diabetes individuals have remained stable in recent years, while mortality rates for the general population have fallen (Diabetes Therapy)

Categories: Audits, News
Tags: mortality, RCGP

Categories: Audits
Tags: mortality, RCGP

Association between dysglycemia and mortality by diabetes status and risk factors of dysglycemia in critically ill patients: a retrospective study

November 12th 2021

The identified factors for dysglycemia could be used for risk assessment in glucose management requirement in critically ill patients, which may improve clinical outcomes (Acta Diabetologica)

Categories: News, Treatment
Tags: dysglycemia, mortality

Categories: Treatment
Tags: dysglycemia, mortality

Optimal glucose, HbA1c, glucose-HbA1c ratio and stress-hyperglycaemia ratio cut-off values for predicting 1-year mortality in diabetic and non-diabetic acute myocardial infarction patients

October 20th 2021

SHR was the most consistent independent predictor of 1-year all-cause mortality in both diabetic and non-diabetic STEMI, whereas glucose was the best predictor in NSTEMI patients (Cardiovascular Diabetology)

Categories: Cardiovascular, News
Tags: HbA1c, mortality, stress-hyperglycaemia

Categories: Cardiovascular
Tags: HbA1c, mortality, stress-hyperglycaemia

Completion of annual diabetes care processes and mortality: A cohort study using the National Diabetes Audit for England and Wales

August 18th 2021

People with diabetes who have fewer routine care processes have higher mortality (Diabetes, Obesity and Metabolism)

Categories: Audits, News
Tags: Care Processes, mortality

Categories: Audits
Tags: Care Processes, mortality

Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

August 1st 2021

The initiation of SGLT-2i as compared with other glucose-lowering drugs in routine clinical practice is associated with decreased risk of heart failure, all-cause death, myocardial infarction and stroke (Cardiovascular Diabetology)

Categories: Cardiovascular, Medication, News
Tags: heart failure, mortality

Categories: Cardiovascular, Medication
Tags: heart failure, mortality

All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease

May 31st 2021

Our data show that two well-established prediction models of all-cause mortality in type 2 diabetes can also be successfully applied in the early stage of the disease, thus becoming powerful tools for educated and timely prevention strategies for high-risk patients (Acta Diabetologica)

Categories: Monitoring, News
Tags: mortality, Type 2 Diabetes

Categories: Monitoring
Tags: mortality, Type 2 Diabetes

Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records

February 6th 2021

The decline in vascular death rates has been accompanied by a diversification of causes in individuals with diagnosed diabetes and a transition from vascular diseases to cancers as the leading contributor to diabetes-related death. Clinical and preventative approaches must reflect this trend to reduce the excess mortality risk in individuals with diabetes (Lancet Diabetes & Endocrinology)

Categories: News, Pathology
Tags: cancer, mortality

Categories: Pathology
Tags: cancer, mortality

Potential Unrealized Mortality Benefit of GLP‐1 Receptor Agonists and SGLT2 Inhibitors

September 10th 2020

This analysis indicates unrealized opportunities to reduce mortality in selected Veterans with T2D and CAD via increased use of GLP‐1RA and SGLT2i (Diabetes, Obesity and Metabolism)

Categories: Medication, News
Tags: GLP‐1RA, mortality, SGLT2 inhibitors

Categories: Medication
Tags: GLP‐1RA, mortality, SGLT2 inhibitors

Organisation of primary diabetes care in people with type 2 diabetes in relation to all-cause mortality: a nationwide register-based cohort study

July 23rd 2020

This nationwide register-based cohort study suggests that the number of WTE GPs devoted to diabetes care have an impact on the risk of early death in people with T2DM (Diabetes Research and Clinical Practice)

Categories: Management, News
Tags: mortality, primary care, Type 2 Diabetes

Categories: Management
Tags: mortality, primary care, Type 2 Diabetes

Pain in Patients With Type 2 Diabetes-Related Polyneuropathy Is Associated With Vascular Events and Mortality

July 23rd 2020

Our study found a significant association between pain in DPN and an increased risk of vascular events and mortality (Journal of Clinical Endocrinology & Metabolism)

 

Categories: Neuropathy, News
Tags: mortality, Type 2 Diabetes

Categories: Neuropathy
Tags: mortality, Type 2 Diabetes

Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a cohort study in people with diabetes

May 20th 2020

Deaths in people with diabetes in England have more than doubled during the COVID-19 epidemic. Hyperglycaemia and obesity in both Type 1 and Type 2 diabetes were independently associated with increased COVID-19 mortality. Risk factor control could diminish the impact of COVID-19 in diabetes (NHS England)

Categories: News, Prevalence
Tags: COVID-19, mortality, Type 1 Diabetes, Type 2 Diabetes

Categories: Prevalence
Tags: COVID-19, mortality, Type 1 Diabetes, Type 2 Diabetes

Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study

May 20th 2020

This nationwide analysis in England demonstrates that all types of diabetes are independently associated with a significant increased risk of in-hospital death with COVID-19 (NHS England)

Categories: News, Prevalence
Tags: COVID-19, mortality, Type 1 Diabetes, Type 2 Diabetes

Categories: Prevalence
Tags: COVID-19, mortality, Type 1 Diabetes, Type 2 Diabetes

Socio‐economic status and mortality in people with type 1 diabetes in Scotland 2006–2015: a retrospective cohort study

January 23rd 2020

Socio‐economic deprivation was associated with a steeper mortality gradient in people with type 1 diabetes than in the population without type 1 diabetes in Scotland. Age‐standardized mortality has decreased over time but socio‐economic inequalities may be increasing. (Diabetic Medicine)

Categories: Epidemiology, News
Tags: mortality, Scotland, Type 1 Diabetes

Categories: Epidemiology
Tags: mortality, Scotland, Type 1 Diabetes

Relationship Between Body Mass Index, Antidiabetic Agents, and Midterm Mortality in Patients With Both Type 2 Diabetes Mellitus and Acute Coronary Syndrome

March 27th 2019

In patients with type 2 diabetes mellitus and acute coronary syndrome, the relationship between body mass index and mortality rate is U‐shaped, with class I obesity representing the nadir and normal weight the peak. The protective effect of obesity disappeared in patients treated with insulin (JAHA)

Categories: News, Pathology
Tags: ACS, BMI, mortality, Type 2 Diabetes

Categories: Pathology
Tags: ACS, BMI, mortality, Type 2 Diabetes

The All-Cause Mortality and a Screening Tool to Determine High-Risk Patients among Prevalent Type 2 Diabetes Mellitus Patients

July 12th 2018

The model has moderate accuracy; the prognostic model can be used as a screening tool to classify T2DM patients who are at higher risk for mortality within five years (Journal of Diabetes Research)

Categories: News, Screening
Tags: mortality, Type 2 Diabetes

Categories: Screening
Tags: mortality, Type 2 Diabetes

Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study

May 9th 2018

Multiple risk factor control (MRFC)  may lower the increased risks for mortality and cardiovascular events in people with diabetes and CKD (BMJ Open)

Categories: Nephropathy, News
Tags: mortality, risk factors, Type 2 Diabetes

Categories: Nephropathy
Tags: mortality, risk factors, Type 2 Diabetes

How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial

February 4th 2018

In this exploratory analysis from the EMPA-REG OUTCOME trial, changes in markers of plasma volume were the most important mediators of the reduction in risk of CV death with empagliflozin versus placebo (Diabetes Care)

Categories: Medication, News
Tags: EMPA-REG, Empagliflozin, mortality

Categories: Medication
Tags: EMPA-REG, Empagliflozin, mortality
  • 1
  • 2
  • 3
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

Boehringer IngelheimAstraZenecaNovo NordiskNapp Diabetes

Silver Sponsors

Abbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)About Ascensia Diabetes Care

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 DPP4 inhibitors Empagliflozin exenatide GLP-1 RA GLP-1RA GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis liraglutide metformin microvascular mortality NAFLD NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Copyright © 2022 Glycosmedia Partnership